AI assistant
DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2022
Aug 9, 2022
32130_dirs_2022-08-09_7c0fa923-c858-4b83-be98-353875760b37.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2022-08-05
Reporting Person: Janssen Robert (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-05 | Common Stock | M | 900 | $10.47 | Acquired | 25607 | Direct |
| 2022-08-05 | Common Stock | S | 900 | $17.0123 | Disposed | 24707 | Direct |
| 2022-08-08 | Common Stock | M | 4450 | $10.47 | Acquired | 29157 | Direct |
| 2022-08-08 | Common Stock | S | 4450 | $17.1607 | Disposed | 24707 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-05 | Stock Option (Right to Buy) | $10.47 | M | 900 | Disposed | 2026-02-21 | Common Stock (900) | Direct |
| 2022-08-08 | Stock Option (Right to Buy) | $10.47 | M | 4450 | Disposed | 2026-02-21 | Common Stock (4450) | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 15, 2021.
F2: This transaction was executed in multiple trades at prices ranging from $17.00 to $17.07; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
F3: This transaction was executed in multiple trades at prices ranging from $17.00 to $17.43; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
F4: This option grant will vest over three (3) years with one-third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.
F5: Not applicable.